The consensus price target hints at a 41.7% upside potential for ANI (ANIP). While empirical research shows that this ...
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's ...
Zacks Investment Research on MSN
ANI (ANIP) upgraded to strong buy: Here's why
ANI Pharmaceuticals (ANIP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Zacks.com on MSN
Is ANIP Undervalued? How to Read Its 9.3x Forward P/E
ANI Pharmaceuticals ANIP has shifted into a specialty-led growth story, with Cortrophin Gel now the main engine and the retina franchise positioned for a reset and recovery. At the same time, the ...
ANI Pharmaceuticals Inc (NASDAQ:ANIP) announced the launch of Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results